Early research (Phase 1)Study completedNCT01122875
What this trial is testing
The Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
Who this might be right for
Multiple Myeloma
Genentech, Inc. 14